Amneal Pharmaceuticals, Inc. (AMRX) › RevenueAmneal Pharmaceuticals, Inc. (AMRX) — RevenueAnnual figures by period end, from SEC filings.2016-12-31: $1.02B2017-12-31: $1.03B2018-12-31: $1.66B2019-12-31: $1.63B2020-12-31: $1.99B2021-12-31: $2.09B2022-12-31: $2.21B2023-12-31: $2.39B2024-12-31: $2.79B2025-12-31: $3.02B$3.02B2016-12-31Revenue (USD)2025-12-31Period endedRevenueChange YoYSource filing2025-12-31$3.02B+8.0%2026-02-27From 2025-01-012024-12-31$2.79B+16.7%2026-02-27From 2024-01-012023-12-31$2.39B+8.2%2026-02-27From 2023-01-012022-12-31$2.21B+5.7%2025-02-28From 2022-01-012021-12-31$2.09B+5.1%2024-03-14From 2021-01-012020-12-31$1.99B+22.5%2023-03-03From 2020-01-012019-12-31$1.63B-2.2%2022-03-01From 2019-01-012018-12-31$1.66B+60.9%2021-03-01From 2018-01-012017-12-31$1.03B+1.5%2020-03-02From 2017-01-012016-12-31$1.02B—2019-03-01From 2016-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)